To investigate the methylation rate of the RIPK3 CpG island with advancing tumor progression, we quantified RIPK3 methylation by pyrosequencing of patient material of naevi, dysplastic naevi, primary melanomas, metastases, and melanoma cell lines. The gene discussed is RIPK3; the disease is melanoma.